| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/12/2002 | CA2443850A1 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 12/12/2002 | CA2438099A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 12/12/2002 | CA2436408A1 Modified psma ligands and uses related thereto |
| 12/12/2002 | CA2412652A1 Remedies for allergic diseases and process for producing the same |
| 12/11/2002 | WO2001083471A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 12/11/2002 | EP1264832A1 Alkaloid halide salts of swainsonine and methods of use |
| 12/11/2002 | EP1264831A1 Cell division inhibitors and process for producing the same |
| 12/11/2002 | EP1264829A1 Oxygen-containing heterocyclic compounds |
| 12/11/2002 | EP1264828A1 New inhibitor of urokinase |
| 12/11/2002 | EP1264827A1 Process for the preparation of Tosylbenzylformamides |
| 12/11/2002 | EP1264821A1 Novel crystal of stilbene derivative and process for producing the same |
| 12/11/2002 | EP1264602A2 Pharmaceutical composition comprising high tapped density fumed silica |
| 12/11/2002 | EP1264601A2 Treatment of a coronary condition by delivery of therapeutics to the pericardial space |
| 12/11/2002 | EP1264600A1 Immune enhancement compositions and use thereof |
| 12/11/2002 | EP1264597A2 Methods and compositions for treating cancer |
| 12/11/2002 | EP1264596A2 Use of a ferulic acid derivative as a preventive or remedy for hypertension |
| 12/11/2002 | EP1264595A1 Use of tocopherol derivatives for stabilizing nano-sized emulsion particles containing lecithin and their external application to the skin |
| 12/11/2002 | EP1264594A2 Melanin production inhibitors and skincare products containing such inhibitors |
| 12/11/2002 | EP1264548A2 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 12/11/2002 | EP1263979A1 Method of purifying a fermentation broth |
| 12/11/2002 | EP1263965A2 Avirulent, immunogenic flavivirus chimeras |
| 12/11/2002 | EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 12/11/2002 | EP1263947A2 Nucleic acid sensor molecules |
| 12/11/2002 | EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 12/11/2002 | EP1263935A1 Scytonemin and methods of using thereof |
| 12/11/2002 | EP1263933A2 Treatment for bone disorders |
| 12/11/2002 | EP1263803A1 Embolic compositions |
| 12/11/2002 | EP1263802A1 Hydrogel biomedical articles |
| 12/11/2002 | EP1263801A1 Tissue bulking and coating compositions |
| 12/11/2002 | EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 12/11/2002 | EP1263786A2 Methods and compositions for immunoregulation |
| 12/11/2002 | EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 12/11/2002 | EP1263766A1 Adam polynucleotides, polypeptides, and antibodies |
| 12/11/2002 | EP1263765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING |
| 12/11/2002 | EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs |
| 12/11/2002 | EP1263762A1 Anti-infective ectatm |
| 12/11/2002 | EP1263761A2 Compounds for pdt |
| 12/11/2002 | EP1263760A1 Novel compounds |
| 12/11/2002 | EP1263759A2 Azaindoles |
| 12/11/2002 | EP1263758A2 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| 12/11/2002 | EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 12/11/2002 | EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 12/11/2002 | EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 12/11/2002 | EP1263753A1 Imidazol derivatives as raf kinase inhibitors |
| 12/11/2002 | EP1263752A2 Lpa receptor agonists and antagonists and methods of use |
| 12/11/2002 | EP1263750A1 Method for the preparation of citalopram |
| 12/11/2002 | EP1263749A1 Taxane anticancer agents |
| 12/11/2002 | EP1263747A1 1,5-benzothiazepines and their use as hypolipidaemics |
| 12/11/2002 | EP1263746A1 Substituted 8, 8a-dihydro-3ah-indeno 1,2-d]thiazoles, a method for their production and their use as medicaments |
| 12/11/2002 | EP1263745A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 12/11/2002 | EP1263743A1 Heterocycle substituted diphenyl leukotriene antagonists |
| 12/11/2002 | EP1263742A1 Oxazolidinone thioamides with piperazine amide substituents |
| 12/11/2002 | EP1263741A1 Bifunctional chelating agent |
| 12/11/2002 | EP1263740A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 12/11/2002 | EP1263739A1 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 12/11/2002 | EP1263737A1 2-phenylcarbamoyl-benzimidazoles |
| 12/11/2002 | EP1263736A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 12/11/2002 | EP1263733A2 Derivatives of quinoline as alpha-2 antagonists |
| 12/11/2002 | EP1263732A1 Corticotropin releasing factor antagonists |
| 12/11/2002 | EP1263730A1 Amine derivatives for the treatment of apoptosis |
| 12/11/2002 | EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/11/2002 | EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 12/11/2002 | EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 12/11/2002 | EP1263726A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 12/11/2002 | EP1263725A1 Novel compounds |
| 12/11/2002 | EP1263724A1 Novel compounds |
| 12/11/2002 | EP1263723A1 Ningalin b analogs employable for reversing multidrug resistance |
| 12/11/2002 | EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 12/11/2002 | EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 12/11/2002 | EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 12/11/2002 | EP1263719A1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them |
| 12/11/2002 | EP1263718A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263715A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263714A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263711A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263525A1 Method for preparing colloidal particles in the form of nanocapsules |
| 12/11/2002 | EP1263504A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 12/11/2002 | EP1263503A2 Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 12/11/2002 | EP1263475A2 Synthetic oligonucleotides as inducers of erythroid differentiation |
| 12/11/2002 | EP1263474A1 A method of sensitising endothelial cells to prodrugs |
| 12/11/2002 | EP1263473A2 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 12/11/2002 | EP1263470A1 METHOD FOR PRODUCING A COENZYME Q10 / $g(g)-CYCLODEXTRIN COMPLEX |
| 12/11/2002 | EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 12/11/2002 | EP1263468A1 Formulation solubilizing water-insoluble agents and preparation method thereof |
| 12/11/2002 | EP1263467A1 Improved paste formulations |
| 12/11/2002 | EP1263466A1 Methods and compositions for dietary supplements |
| 12/11/2002 | EP1263465A2 Photodynamic cellular and acellular organism eradication using a photosensitive material and surfactant |
| 12/11/2002 | EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 12/11/2002 | EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 12/11/2002 | EP1263454A2 Methods for enhancing the bioavailability of a drug |
| 12/11/2002 | EP1263452A2 Methods and compositions for generating angiostatin |
| 12/11/2002 | EP1263446A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 12/11/2002 | EP1263445A1 Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin, metronidazole and a gastrointestinal hydrogen pump inhibitor |
| 12/11/2002 | EP1263444A2 Use of xanthine derivatives for preparing a medicine for preventing and treating osteoporosis |
| 12/11/2002 | EP1263443A1 Metalloproteinase inhibitors for the treatment of respiratoty diseases |
| 12/11/2002 | EP1263442A1 TETRACYCLINE COMPOUNDS FOR TREATMENT OF i CRYPTOSPORIDIUM PARVUM /i RELATED DISORDERS |
| 12/11/2002 | EP1263441A2 Acetylsalicylic acid solutions |
| 12/11/2002 | EP1263440A2 Cephalotaxine alkaloid combination compositions and uses thereof |
| 12/11/2002 | EP1263439A2 Sustained release ranolazine formulations |
| 12/11/2002 | EP1263438A2 Neutral antagonists and use thereof in treating drug abuse |